Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05215106
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2021-12-22
Brief Title:
Short-term Pre-OPerative Durvalumab MEDI 4736 in Early Small Triple Negative Breast Cancer Patients POP-Durva
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Organization Data
Organization:
Gustave Roussy Cancer Campus Grand Paris
Class:
OTHER
Study ID:
2020-006106-23
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |